Dementia biomarkers -- phosphorylated tau (P-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) - ...

Rather than looking for amyloid-beta plaques like many other Alzheimer's tests, this one hunts for tiny clumps of tau protein, which are more often associated with cognitive decline. The ...

Those findings were integrated with data collected from the participants on cerebrospinal fluid and brain-scan biomarkers of amyloid- β and tau protein, cognitive function, age, sex and Alzheimer ...

A long-term study reveals how age, sex, genetics, and menopause influence blood biomarkers related to dementia. The study ...

Phosphorylation enables tau protein to undergo reversible liquid–liquid phase separation (LLPS), forming micrometer-sized droplets, a property not seen in unmodified tau.

14 With several assays to measure tau pathology available, we are also one step closer to integrating blood-based biomarkers into routine clinical practice, and not just clinical trials.

Glial fibrillary acidic protein, or GFAP ... A year later, Ashford’s blood biomarkers told a completely different story about her brain health. Her p-tau 217 dropped by 43% and her p-tau ...

The study also showed that female participants may be more at risk of a heavier buildup of tau protein than male participants. "We were surprised to see that people with a father with Alzheimer's ...

But now, Canadian scientists say children who have Dad's with Alzheimer's are more prone to one toxic protein, tau, spreading in the brain. Significant clumps of this protein, as well as anothe ...